NCT07861308Not yet recruiting
Diabetes Distress, Medication Adherence Barriers, Self-Management, and Glycemic Control in Adults With Type 2 Diabetes
The Mediating Role of Diabetes Self-Management in the Relationship Between Diabetes Distress, Medication Adherence Barriers, and Glycemic Control Among Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 6 Oct 2026
Brief summary (registry, in English)
This observational study will examine the relationships among diabetes distress, practical barriers to medication use, diabetes self-management, and glycemic control in adults with type 2 diabetes. Participants who meet the study criteria and agree to take part will complete questionnaires about their personal and clinical characteristics, diabetes distress, medication-taking barriers, and diabetes self-management. With their permission, the most recent HbA1c result measured within the previous three months will be obtained from their medical record. No treatment or medication changes will be made for this study. The researchers plan to include at least 137 participants.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 137 (estimated)
- First submitted
- 30 Sept 2026
- Start date
- 15 Dec 2026
- Primary completion date
- 15 Aug 2027
- Lead sponsor
- Bilecik Seyh Edebali Universitesi
- Diseases
- Type 2 diabetes
- NCT number
- NCT07861308
What you commit to
- Study type: Observational
- Planned participants: 137
- From 15 Dec 2026 to the primary completion date, 15 Aug 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of type 1 diabetes mellitus or gestational diabetes.
Lab values
- No HbA1c result measured within the previous three months, or the result is unavailable.
Other
- Withdraws from the study.
- Study forms are substantially incomplete.
Who the study is looking for
- Age 18 years or older.
- Diagnosis of type 2 diabetes mellitus for at least six months.
- Attending the Diabetes Nursing Unit.
- Using oral antidiabetic medication and/or insulin.
- Having an HbA1c result measured within the previous three months.
- Able to communicate in Turkish.
- Voluntarily agrees to participate in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.